Novartis (NVS)

Add to Watchlists
Create an Alert
83.28 -0.23  -0.28% NYSE Aug 23, 16:59 Delayed 2m USD

Novartis Revenue (TTM):

49.23B for June 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Novartis Revenue (TTM) Chart

Export Data
Save Image
Print Image

Novartis Historical Revenue (TTM) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2017 49.23B
March 31, 2017 49.41B
Dec. 31, 2016 49.44B
Sept. 30, 2016 49.63B
June 30, 2016 49.78B
March 31, 2016 50.00B
Dec. 31, 2015 50.39B
Sept. 30, 2015 50.94B
June 30, 2015 51.75B
March 31, 2015 52.80B
Dec. 31, 2014 53.63B
Sept. 30, 2014 53.91B
June 30, 2014 53.51B
March 31, 2014 52.84B
Dec. 31, 2013 54.02B
Sept. 30, 2013 49.87B
June 30, 2013 51.00B
March 31, 2013 52.26B
Dec. 31, 2012 51.97B
Sept. 30, 2012 57.49B
June 30, 2012 58.48B
March 31, 2012 59.07B
Dec. 31, 2011 59.38B
Sept. 30, 2011 58.84B
June 30, 2011 56.63B
   
March 31, 2011 53.43B
Dec. 31, 2010 51.56B
Sept. 30, 2010 50.24B
June 30, 2010 48.71B
March 31, 2010 47.53B
Dec. 31, 2009 45.10B
Sept. 30, 2009 42.31B
June 30, 2009 42.05B
March 31, 2009 42.29B
Dec. 31, 2008 42.58B
Sept. 30, 2008 41.53B
June 30, 2008 40.32B
March 31, 2008 38.73B
Dec. 31, 2007 37.89B
Sept. 30, 2007 38.25B
June 30, 2007 37.45B
March 31, 2007 36.56B
Dec. 31, 2006 35.34B
Sept. 30, 2006 31.66B
June 30, 2006 31.13B
March 31, 2006 30.49B
Dec. 31, 2005 29.68B
Sept. 30, 2005 30.16B
June 30, 2005 28.72B
March 31, 2005 27.83B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Advertisement

NVS Revenue (TTM) Benchmarks

Companies
Roche Holding 52.27B
Amgen 23.05B
AstraZeneca 22.29B

NVS Revenue (TTM) Range, Past 5 Years

Minimum 49.23B Jun 2017
Maximum 57.49B Sep 2012
Average 51.69B

NVS Revenue (TTM) Excel Add-In Codes

  • Metric Code: revenues_ttm
  • Latest data point: =YCP("NVS", "revenues_ttm")
  • Last 5 data points: =YCS("NVS", "revenues_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.